© 2026 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy
Publication / Presentation Year | Therapeutic Area | Journal / Conference | Title |
|---|---|---|---|
2026 | Virology, Infectious Disease | Administration timing of respiratory syncytial virus preventatives among commercially insured populations in the United States: 2024 – 2025 RSV season | |
2026 | Methodology, Dataset Validation | Validation of the Medicare-Enhanced Laboratory and Demographics (MELD™) Dataset: A comprehensive psychometric, epidemiologic, and predictive-utility assessment of a 60-million-patient real-world evidence resource | |
2026 | Women's Health, Mental Health, Healthcare Policy | Socioeconomic status and postpartum depression risk after the Dobbs v Jackson Women’s Health Organization Decision, based on state trigger laws | |
2026 | Oncology | Prevalence, economic burden, and healthcare utilization among Medicare and commercially insured oropharyngeal cancer patients | |
2026 | Oncology | Association between survival outcomes in patients with multiple myeloma and treatment facility volume | |
2026 | Oncology | Cancer Med (In press) | Analysis of treatment patterns in patients with mucosal melanoma using real-world data in the SEER-Medicare–linked database |
2026 | Mental Health, Healthcare Policy | The effect of Medicaid reimbursement for Psychiatrists on the health care burden of serious mental illness | |
2026 | Women's Health, Mental Health, Healthcare Policy | Womens Health Issues (In press) | Evaluating the relationship between maternal healthcare policies and practices on postpartum depression (PPD) diagnosis incidence in the US |
2026 | Women's Health, OB/GYN | Contraception (In press) | Safety of medication abortion: Analysis of insurance claims, 2017-2024 |
2026 | Oncology, Rare Disease, Modeling / Methodology | AMCP Annual Meeting | Budget impact/cost-offset model comparing once-daily extended-release vs twice-daily immediate-release ruxolitinib in myelofibrosis: A US payer perspective |
2026 | Endocrinology, Diabetes | AMSUS Annual Meeting | Evaluating prevalence and incidence of type 1 diabetes in the US Department of War population |
2026 | Vaccine, Virology | RSVVW | Administration timing of respiratory syncytial virus (RSV) preventives for infants in the United States: A descriptive retrospective observational study of the 2024 – 2025 RSV season |
2025 | Endocrinology, Nephrology | External control arm with real-world data to assess the effect of semaglutide on chronic kidney disease risk among patients with type 2 diabetes | |
2025 | Healthcare Policy, Mental Health | The impact of copay accumulators and maximizers on treatment patterns, adherence, and costs among patients with major depressive and bipolar disorders treated with branded therapies | |
2025 | Healthcare Policy, Mental Health | Impact of Medicaid Institution for Mental Diseases exclusion on serious mental illness outcomes | |
2025 | Mental Health, Healthcare Policy | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness | |
2025 | Rare Disease, Dermatology, Immunology | Analysis of rare events in healthcare intervention using Department of Defense data: Intravenous immune globulin therapy for bullous pemphigoid | |
2025 | Mental Health, Women's Health, Healthcare Policy | The effect of Dobbs v. Jackson Women’s Health Organization on clinical diagnosis of postpartum depression | |
2025 | Oncology | ISPOR Europe | Overall treatment landscape of mucosal melanoma |
2025 | Mental Health, Healthcare Policy | ISPOR Europe | Socioeconomic disparities in access to treatment for major depressive disorder: The role of accumulator and maximizer insurance plans |
2025 | Mental Health | ISPOR Europe | Comparative prevalence of suicidal ideation and self-harm history: Rexulti vs other oral atypical antipsychotics |
2025 | Healthcare Policy | ISPOR Europe | Effect of the Inflation Reduction Act on drug innovation |
2025 | Women's Health, Infection | ISPOR Europe | Does the abortion pill harm women? Serious adverse events following mifepristone abortion in US commercial and Medicaid populations |
2025 | Healthcare Policy, Mental Health | ISPOR Europe | Socioeconomic disparities in postpartum depression following abortion restrictions: A difference-in-differences analysis of Medicaid data post-Dobbs |
2025 | Mental Health / Healthcare Policy | AMCP Nexus | The impact of copay accumulators and maximizers on treatment patterns and costs among patients with major depressive and bipolar disorders treated with branded mental health treatments |
2025 | Neurology | AMCP Nexus | Improved outcomes in patients with multiple sclerosis initiating cladribine tablets compared with those denied health insurance coverage in the United States |
2025 | Women's Health / Mental Health | AMCP Nexus | Socioeconomic vulnerabilities and postpartum depression: Assessing the aftermath of Dobbs v Jackson in trigger and non-trigger states |
2025 | Mental Health | Psych Congress | Real-world healthcare resource utilization and costs among individuals living with schizophrenia who transitioned to aripiprazole 2-month ready-to-use formulation |
2025 | Mental Health | Psych Congress | Real-world healthcare resource utilization and costs among US individuals living with bipolar-I disorder who transitioned to aripiprazole 2-month ready-to-use formulation |
2025 | Mental Health | Psych Congress | Real-world impact of transitioning from oral or once-monthly injectable aripiprazole to a 2-month ready-to-use aripiprazole formulation on adherence and healthcare utilization in US adults diagnosed with schizophrenia |
2025 | Mental Health | Academy of Managed Care Pharmacy (AMCP) Annual Meeting | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2025 | Women's Health / Mental Health | Academy of Managed Care Pharmacy (AMCP) Annual Meeting | Real-world treatment patterns, healthcare resource utilization and costs for Medicaid patients with a postpartum depression diagnosis |
2025 | Mental Health | ISPOR Annual Meeting | Shades of blue: Investigating racial, socioeconomic, and family dynamics in depression among teen girls |
2025 | Women's Health / Mental Health | ISPOR Annual Meeting | Postpartum depression: Assessing the aftermath of Dobbs v. Jackson in trigger and non-trigger states |
2025 | Endocrinology / Nephrology | ISPOR Annual Meeting | External control arm with real world data to assess the effect of semaglutide on chronic kidney disease risk among patients with type 2 diabetes |
2025 | Hepatology | ISPOR Annual Meeting | Machine learning algorithms for identifying undiagnosed nonalcoholic steatohepatitis: A Veterans Affairs health system study |
2025 | Obesity / Cardiovascular | ISPOR Annual Meeting | Socioeconomic status and anti-obesity medications: Impact on cardiovascular risk in Medicare patients with obesity |
2025 | Mental Health | ISPOR Annual Meeting | Comparison of suicidal ideation or personal history of self harm among patients with use of Rexulti and all antipsychotics |
2025 | Mental Health | Psych Elevate Congress | Treatment patterns and healthcare resource utilization among patients receiving the long-acting injectable antipsychotic TV-46000 vs second-generation oral antipsychotics |
2025 | Mental Health | Psych Elevate Congress | Real-world clinical outcomes among patients receiving the long-acting injectable antipsychotic TV-46000 versus second-generation oral antipsychotics |
2025 | Public Health, Mental Health, Addiction | Prevalence and risk factors among patients with alcohol use disorder during COVID-19: National Survey on Drug Use and Health Analysis | |
2025 | Mental Health, Women's Health | American College of Obstetricians and Gynecologists (ACOG) Annual Clinical & Scientific Meeting | Evaluating the relationship between Medicaid postpartum depression (PPD) screening and coverage policies on PPD diagnosis incidence in the United States |
2025 | Obesity, Endocrinology | Tirzepatide and semaglutide for the treatment of obstructive sleep apnea and obesity: A retrospective analysis | |
2024 | Oncology | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide | |
2024 | Obesity, Endocrinology | The association between weight loss medications and cardiovascular complications | |
2024 | Obesity, Endocrinology | The impact of newly approved anti-obesity medications on osteoarthritis | |
2024 | Obesity, Endocrinology | Impact of semaglutide on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Obesity, Endocrinology | Semaglutide and tirzepatide use and reduction of cardiovascular risks in adults with overweight and obesity | |
2024 | Mental Health, Neurology | Neighborhood socioeconomic status and postpartum depression among commercial health insurance enrollees: A retrospective cohort study | |
2024 | Hepatology, Methodology | Artificial intelligence in identifying patients with undiagnosed nonalcoholic steatohepatitis | |
2024 | Mental Health | Behind the sadness of teen girls: A retrospective survey analysis | |
2024 | Mental Health | Mental health disparities in young adults with arrest history: A survey-based, cross-sectional analysis | |
2024 | Healthcare Policy, Mental Health, Neurology | Psych Congress | Open access to antipsychotics in state Medicaid programs: The effect on healthcare resource utilization and costs among patients with serious mental illness |
2023 | Dataset Comparison | Use of open claims vs closed claims in health outcomes research | |
2023 | Virology | Short-term and long-term behavioral effects of vaccination mandates | |
2023 | Mental Health | Factors associated with the prevalence and treatment of depression in adolescent males in the US during the period of COVID-19 pandemic | |
2023 | Obesity, Endocrinology | Relationship between body mass index and diagnosis of overweight or obesity in Veterans Administration population | |
2019 | Mental Health / Neurology | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2024 | Obesity / Endocrinology / Mental Health / Neurology | Comparative effect of Ozempic, Wegovy and Mounjaro on the incidence of alcohol and substance use disorder in patients with obesity | |
2024 | Mental Health / Neurology | Socioeconomic status and postpartum depression among commercial health insurance enrollees | |
2024 | Mental Health / Neurology | AMCP Annual Meeting | Open access for mental health medication: Impact on state Medicaid budgets |
2023 | Mental Health / Neurology | ISPOR EU | Mental health disparities for young adults with arrest history: A survey-based, cross-sectional analysis |
2024 | Obesity / Endocrinology | A retrospective analysis of the impact of approved anti-obesity medications on the risk of cardiovascular disease in patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of cardiovascular disease, healthcare resource use and costs among patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of osteoarthritis, healthcare resource use and costs among patients with obesity: A retrospective cohort study BEST RESEARCH POSTER AWARD | |
2024 | Obesity / Endocrinology | Anti-obesity medications and related osteoarthritis risk among patients with obesity | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the risk of obstructive sleep apnea in patients with obesity: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on the incidence of obstructive sleep apnea, healthcare resource utilization and costs among patients with obesity: A retrospective cohort study FINALIST AWARD | |
2024 | Obesity / Endocrinology | Measuring the cardiovascular benefits of anti-obesity medications | |
2024 | Obesity / Endocrinology | Head-to-head comparison of healthcare costs and utilization among patients with semaglutide vs tirzepatide use | |
2024 | Obesity / Endocrinology | Likelihood of osteoarthritis among users of anti-obesity medications | |
2024 | Obesity / Endocrinology | Likelihood of obstructive sleep apnea among patients with obesity and anti-obesity medication use | |
2024 | Obesity / Endocrinology | Effect of anti-obesity medications on cardiovascular events in the Veterans Affairs patient population | |
2024 | Obesity / Endocrinology | Effect of weight loss medications on cardiovascular risk among active US military personnel BRONZE RIBBON AWARD | |
2024 | Obesity / Endocrinology | Cardiovascular benefits of weight loss medications: An analysis of Mounjaro and Wegovy in the US Medicare population | |
2024 | Virology | American Public Health Association (APHA) Annual Meeting & Expo | The association between socioeconomic status and the likelihood and severity of RSV-attributable lower respiratory infections in infants |
2024 | Virology | Infectious Diseases Society for Obstetrics and Gynecology (IDSOG) Annual Meeting | The association between socioeconomic status and maternal risk factors on the likelihood and severity of RSV-attributable lower respiratory infections from MarketScan data |
2024 | Oncology | The cardiovascular effect of abiraterone and enzalutamide among Veterans Affairs’ metastatic castration-resistant prostate cancer patients PODIUM PRESENTATION | |
2024 | Obesity / Endocrinology | The effect of newly approved obesity medications on cardiovascular complications | |
2024 | Obesity / Endocrinology / Mental Health | The effect of approved anti-obesity medications in patients with alcohol and substance use disorder | |
2024 | Obesity / Endocrinology | The impact of approved anti-obesity medications on osteoarthritis risk in patients with obesity: A retrospective cohort study | |
2024 | Hepatology / Methodology | Predictive risk score for nonalcoholic steatohepatitis among patients in the Department of Defense population | |
2024 | Mental Health / Neurology | Psych Congress | The effect of Medicaid reimbursement policies on serious mental illness outcomes |
2024 | Mental Health / Neurology | Psych Congress | The effect of the Medicaid institutions for mental disease exception on serious mental illness outcomes |
2024 | Obesity / Endocrinology | Impact of Ozempic vs Wegovy on osteoarthritis risk in obese patients: A retrospective cohort study | |
2024 | Obesity / Endocrinology | The effect of approved obesity medications on obesity’s cardiovascular related comorbidities | |
2023 | Oncology | AMCP Nexus | Cardiovascular events among patients with prostate cancer treated with abiraterone and enzalutamide in Veteran Affairs |
2023 | Virology / Vaccine | ISPOR EU | The short-run and long-run behavioral effects of vaccination enforcement in Turkey |
2023 | Immunology | ISPOR EU | Direct medical costs associated with rheumatoid arthritis in Turkey: Analysis from a national claims database |
2023 | Oncology | ISPOR Annual | Effect of surgical choices on the cost of breast cancer care |
2023 | Obesity / Endocrinology | ISPOR Annual | Relationship between body mass index and diagnosis of overweight or obesity in Veteran’s Administration population |
2023 | Hepatology / Methodology | ISPOR Annual | Applying machine learning techniques to identify undiagnosed patients with nonalcoholic steatohepatitis |
2023 | Virology / Vaccine | ISPOR Annual | The short run and long run behavioral effects of COVID-19 vaccination enforcement |
2023 | Immunology | ISPOR Annual | Analysis of rare events in outcomes research using Department of Defense data: Intravenous immune globulin therapy for bullous pemphigoid |
2023 | Database Comparison | ISPOR Annual | Use of open claims vs closed claims on health outcomes research |
2023 | Methodology | ISPOR Annual | Review of machine learning based disease diagnosis modeling |
2023 | Cardiovascular | Geographic variation in clinical outcomes and anticoagulation among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Temporal trends in anticoagulation use and clinical outcomes among Medicare beneficiaries with non-valvular atrial fibrillation | |
2023 | Cardiovascular | Contemporary prevalence estimates of undiagnosed and diagnosed atrial fibrillation in the United States | |
2023 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in patients with venous thromboembolism with risk factors for bleeding or for recurrences | |
2023 | Cardiovascular | Delaying clinical events among patients with non-valvular atrial fibrillation treated with oral anticoagulants: Insights from the ARISTOPHANES study | |
2023 | Cardiovascular | Effectiveness and safety of direct oral anticoagulants among patients with non-valvular atrial fibrillation and multimorbidity | |
2022 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding | |
2022 | Cardiovascular | Risk levels and adverse clinical outcomes among patients with nonvalvular atrial fibrillation receiving oral anticoagulants | |
2023 | Cardiovascular | Oral anticoagulant underutilization among elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events: A retrospective analysis of administrative claims databases | |
2022 | Cardiovascular | Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database | |
2022 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Virology / Vaccine / Public Health | Population density index and its use for distribution of Covid-19: A case study using Turkish data | |
2021 | Immunology | Prevalence of mastocytosis and Hymenoptera venom allergy in the United States | |
2021 | Cardiovascular / Oncology | Effectiveness and safety of oral anticoagulants among nonvalvular atrial fibrillation patients with active cancer | |
2021 | Cardiovascular | Effectiveness and safety of apixaban versus warfarin among older patients with venous thromboembolism with different demographics and socioeconomic status | |
2021 | Cardiovascular | Non-persistence to oral anticoagulation treatment in non-valvular atrial fibrillation patients in the United States | |
2021 | Cardiovascular | Oral anticoagulants for nonvalvular atrial fibrillation in patients with high risk of gastrointestinal bleeding | |
2021 | Cardiovascular | Use of non-vitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and multimorbidity | |
2021 | Cardiovascular | Burden of major gastrointestinal bleeding among oral anticoagulant-treated non-valvular atrial fibrillation patients | |
2021 | Cardiovascular | Clinical and economic outcomes among non-valvular atrial fibrillation patients with coronary artery disease and/or peripheral artery disease | |
2021 | Cardiovascular | Effectiveness and safety of apixaban vs warfarin in venous thromboembolism patients with obesity and morbid obesity | |
2021 | Cardiovascular | Oral anticoagulants for non-valvular atrial fibrillation in frail elderly patients: Insights from the ARISTOPHANES study | |
2021 | Cardiovascular | Safety and effectiveness of apixaban compared with warfarin among clinically relevant subgroups of venous thromboembolism patients in the United States Medicare population | |
2021 | Cardiovascular | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients with polypharmacy | |
2020 | Virology / Infectious Disease | Real-world adherence and persistence for newly-prescribed HIV treatment: Single versus multiple tablet regimen comparison among US Medicaid beneficiaries | |
2020 | Oncology | Economic outcomes in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate plus prednisone | |
2020 | Oncology / Rare Diseases | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data | |
2020 | Cardiovascular / Pulmonary | Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: A retrospective database analysis | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants among NVAF patients with obesity: Insights from the ARISTOPHANES Study | |
2020 | Cardiovascular | Effectiveness and safety of oral anticoagulants in patients with nonvalvular atrial fibrillation and diabetes mellitus | |
2020 | Hematology / Rare Diseases / Hereditary Diseases | Medical resource use and costs of treating sickle cell-related vaso-occlusive crisis episodes: A retrospective claims study | |
2020 | Oncology / Rare Diseases | Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis | |
2020 | Infectious Disease / Virology | Predictors and outcomes of hospitalization for influenza: Real-world evidence from the United States Medicare population | |
2020 | Respiratory / Virology | A real-world analysis of patient characteristics and predictors of hospitalization among US Medicare beneficiaries with respiratory syncytial virus infection | |
2020 | Mental Health | An evaluation of the clinical and economic burden among older adult Medicare-covered beneficiaries with treatment-resistant depression | |
2019 | Hematology / Rare Disease / Hereditary Disease | Treatment patterns and economic burden of sickle-cell disease patients prescribed hydroxyurea: a retrospective claims-based study | |
2019 | Cardiovascular | Healthcare resource utilization and expenditures among newly diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants | |
2019 | Cardiovascular | Safety, effectiveness, and health care cost comparisons among elderly patients with venous thromboembolism prescribed warfarin or apixaban in the United States Medicare population | |
2019 | Cardiovascular | Comparisons between oral anticoagulants among older nonvalvular atrial fibrillation patients | |
2019 | Cardiovascular | Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS Medicare population | |
2019 | Cardiovascular | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and heart failure | |
2019 | Cardiovascular | Cardiovascular outcomes among elderly patients with heart failure and coronary artery disease and without atrial fibrillation: A retrospective cohort study | |
2019 | Cardiovascular | Risk of venous thromboembolism after new onset heart failure | |
2019 | Cardiovascular | The value of sPESI for risk stratification in patients with pulmonary embolism | |
2019 | Oncology | ISPOR Annual | Real-world evidence of the economic burden and risk factors for hospitalization among patients with myeloma in the US Veterans Health Administration population |
2019 | Cardiovascular | ISPOR Annual | Assessing the risk factors of heart failure among patients in the US Department of Defense population |
2019 | Hepatology | ISPOR Annual | Assessing the economic burden and hospitalization among patients with non-alcoholic steatohepatitis in the US Veterans Health Administration population |
2019 | Respiratory | ISPOR Annual | Examining the risk factors of chronic obstructive pulmonary disease among patients in the Department of Defense population |
2019 | Immunology | ISPOR Annual | Assessing the economic burden and predictors of hospitalization among US veteran patients with rheumatoid arthritis: A retrospective case-control study |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc | Survival rates and economic outcomes in chemotherapy-naïve metastatic castrate resistant prostate cancer patients treated with abiraterone acetate or enzalutamide |
2019 | Oncology | Annual Meeting of the American Urological Association (AUA) Education and Research Inc. | Impact of prostate specific antigen doubling time on metastasis and increased costs associated with progression to metastatic castrate-resistant prostate cancer |
2019 | Respiratory | AMCP Annual | Assessing economic burden and hospitalization among asthma patients in the US Veterans Health Administration population |
2019 | Oncology / Rare Disease | European School of Haematology: How to Diagnose and Treat CML/MPN | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Impact of prostate specific antigen doubling time on time to metastasis and overall survival in nonmetastatic castration-resistant prostate cancer patients |
2019 | Oncology | American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium | Overall survival by race in chemotherapy-naïve metastatic castration-resistant prostate cancer (mCRPC) patients treated with abiraterone acetate or enzalutamide |
2019 | Public Health | Network among HTA ecosystem | |
2019 | Public Health / Policy | Does the unification of health financing affect the distribution pattern of out‐of‐pocket health expenses in Turkey? | |
2019 | Obesity / Endocrinology | Treatment patterns, glycemic control and bodyweight with canagliflozin 300 mg versus GLP1 RAs in type II diabetes patients | |
2019 | Cardiovascular Diseases | Predictors of hospital length of stay among patients with low-risk pulmonary embolism | |
2019 | Respiratory | The burden of hypoxic respiratory failure in preterm and term/near-term infants in the United States 2011-2015 | |
2019 | Mental Health | Health outcomes among patients diagnosed with schizophrenia in the US Veterans Health Administration population who transitioned from once-monthly to once-every-3-month paliperidone palmitate: An observational retrospective analysis | |
2019 | Oncology / surgery | Impact of surgical approach on short-term oncological outcomes and recovery following low anterior resection for rectal cancer | |
2019 | Oncology / surgery | The effect of the breast cancer provider discussion law on breast reconstruction rates in New York state | |
2019 | Oncology / Hematology / Rare disease | Hematocrit levels and thrombotic events in patients with polycythemia vera: An analysis of Veterans Health Administration data | |
2019 | Respiratory | Reduction in hospital readmission rates among Medicare beneficiaries with chronic obstructive pulmonary disease: A real-world outcomes study of nebulized bronchodilators | |
2019 | Hematology / Hereditary Diseases / Rare Diseases | Sickle cell disease complications: Prevalence and resource utilization | |
2019 | Hematology / Hereditary Diseases / Rare Diseases | Evaluation of vaso-occlusive crises in United States sickle cell disease patients: A retrospective claims-based study | |
2018 | Rare Diseases | Health care costs and comorbidities for patients with inclusion body myositis | |
2018 | Surgery | Smoking and postoperative complications in plastic and general surgical procedures: A propensity-score matched analysis of 294,903 patients from the NSQIP database from 2005-2014 | |
2018 | Oncology | Cytoreductive treatment patterns among US veterans with polycythemia vera | |
2018 | Oncology | Costs of relapsed diffuse large B-cell lymphoma among Medicare patients | |
2018 | Oncology | Taxane chemotherapy versus anti-androgen agents as first-line therapy for metastatic castration-resistant prostate cancer | |
2018 | Immunology / Dermatology | Comorbidity and economic burden among moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population | |
2018 | Surgery | The effect of hospital familiarity with complex procedures on overall healthcare burden | |
2018 | Immunology / Dermatology | Evaluating the impact of treatment persistence on the economic burden of moderate-to-severe psoriasis and/or psoriatic arthritis patients in the US Department of Defense population | |
2018 | Neurology | An analysis of episodes of care among newly diagnosed Alzheimers patients: US Medicare population | |
2018 | Neurology | Economic burden, mortality and institutionalization in patients newly diagnosed with Alzheimer’s disease | |
2018 | Infectious Disease | Real-world persistence for newly prescribed HIV-1 treatment: Single versus multiple tablet regimen comparison | |
2018 | Neurology | Adherence with extended-release oxcarbazepine (Oxtellar XR®) vs immediate-release oxcarbazepine: Analysis of pooled data from four national pharmacy claims databases | |
2018 | Gastrointestinal | Propensity score-matched analysis of clinical and financial outcomes after robotic and laparoscopic colorectal resection. | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants among non-valvular atrial fibrillation patients: The ARISTOPHANES Study | |
2018 | Cardiovascular Diseases | Effectiveness and safety of oral anticoagulants in older adults with non-valvular atrial fibrillation and concomitant coronary/peripheral artery disease | |
2018 | Cardiovascular Diseases | J Manag Care Specialty Pharm | Real-world comparative effectiveness, safety, and health care costs of oral anticoagulants in non-valvular atrial fibrillation patients in the United States Department of Defense population |
2018 | Cardiovascular Diseases | A real-world observational study of hospitalization and health care costs among non-valvular atrial fibrillation patients prescribed oral anticoagulants in the United States Medicare population | |
2018 | Cardiovascular Diseases | East meets West: The influence of racial, ethnic and cultural risk factors on cardiac surgical risk model performance | |
2018 | Cardiovascular Diseases | Effect of renal function on dosing of non-vitamin K-antagonist direct oral anticoagulants among patients with non-valvular atrial fibrillation | |
2018 | Immunology / Rheumatology | Burden of rheumatoid arthritis in the US elderly population: Comorbidities, healthcare resource utilization, and costs | |
2018 | Women's Health | Long-term outcomes after elective sterilization procedures—A comparative retrospective cohort study of Medicaid patients | |
2018 | Immunology / Rheumatology | Evaluating the effect of treatment persistence on the economic burden of moderate to severe psoriasis and/or psoriatic arthritis patients in the U.S. Department of Defense population | |
2018 | Policy / Public Health | The relationship between medical innovation and health expenditure before and after health reform | |
2018 | Oncology / Surgery | Visceral fat area, not body mass index, predicts postoperative 30-day morbidity in patients undergoing colon resection for cancer | |
2018 | Women's Health | Effectiveness of a private, orthopedic practice-based osteoporosis management program to reduce the risk of subsequent fractures | |
2018 | Policy / Public Health | Understanding the relationship between effectiveness and outcome indicators to improve quality in healthcare | |
2018 | Cardiovascular | Outcomes and prognostic factors for postsurgical pulmonary vein stenosis in the current era | |
2018 | Gastrointestinal | Alvimopan, regardless of ileus risk, significantly impacts ileus, length of stay, and readmission after intestinal surgery | |
2018 | Oncology | American Society of Hematology (ASH) Annual Meeting | Burden of CRAB events by relapse in patients with newly diagnosed multiple myeloma not eligible for stem cell transplant |
2018 | Oncology | American Society of Hematology (ASH) Annual Meeting | Elevated white blood cell levels and thrombotic events in patients with polycythemia vera: A real-world analysis of Veterans Health Administration data |
2018 | Oncology | ISPOR Europe | Healthcare utilization and economic burden on patients with bladder cancer in the US Department of Defense population |
2018 | Oncology | ISPOR Europe | Assessing the economic burden and 30- day readmission rates among patients with bladder cancer in the US Veterans Health Administration population |
2018 | Mental Health | US Psych Congress | Outcomes related to transition to once-every-three-monthly paliperidone palmitate among veterans with schizophrenia |
2018 | Mental Health | US Psych Congress | Economic burden of illness among US veterans with treatment-resistant depression |
2018 | Oncology | Academy of Managed Care Pharmacy (AMCP) Nexus | Economic burden of chemotherapy naïve metastatic castrate resistant prostate cancer patients treated with abiraterone acetate or enzalutamide in the United States |
2018 | Oncology | Academy of Managed Care Pharmacy (AMCP) Nexus | Increased costs associated with progression to metastatic castrate-resistant prostate cancer |
2017 | Public Health | Socio-economic status and self-rated health: Are they good predictors of income? An analysis of survey panel data from Turkey | |
2017 | Public Health | Spatial distribution of total number of medical devices in Turkey: A classification analysis | |
2017 | Mental Health | Epidemiology and economic burden of serotonin syndrome with concomitant use of serotonergic agents: A retrospective study utilizing two large US claims databases | |
2017 | Endocrinology | The use of decomposition methods in real- world treatment benefits evaluation for patients with type 2 diabetes initiating different injectable therapies: Findings from the INITIATOR study | |
2017 | Cardiology | Benefit of early discharge among patients with low-risk pulmonary embolism | |
2017 | Women's Health | Examining the effect of medication adherence on risk of subsequent fracture among women with a fragility fracture in the US Medicare population | |
2017 | Cardiology | Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran, or rivaroxaban compared with warfarin in the United States Medicare population | |
2017 | Neurology | A real-world analysis of treatment patterns for cholinesterase inhibitors and memantine among newly-diagnosed Alzheimer’s disease patients | |
2017 | Cardiology | Overall effectiveness of rivaroxaban in patients with pulmonary embolism | |
2017 | Women's Health | Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population | |
2017 | Public Health | Failure of efforts to contain costs of care after colorectal procedures: Nationwide trends in length of stay, costs and post-acute care utilization | |
2017 | Cardiology | External validation of a claims-based and clinical approach for predicting post- pulmonary embolism outcomes among United States veterans | |
2017 | Mental Health | Healthcare resource utilization and costs of California- Medicaid patients with schizophrenia treated with paliperidone palmitate once monthly or atypical oral antipsychotic treatment | |
2016 | Policy | Creating national weights for a patient-level longitudinal database | |
2016 | Infectious Disease | Burden of Clostridium difficile-associated disease among patients residing in nursing homes: A population-based cohort study | |
2016 | Infectious Disease | Mortality and costs in Clostridium difficile infection disease among the elderly in the US | |
2016 | Endocrinology | Comparative persistence and adherence with newer anti-hyperglycemic agents to treat patients with type 2 diabetes in the United States | |
2016 | Infectious Disease | Development and validation of a risk score for clostridium difficile infection in Medicare beneficiaries: A population-based cohort study | |
2016 | Cardiology | Comparison of hospital length of stay and hospitalization costs among patients with non-valvular atrial fibrillation treated with apixaban or warfarin: An early view | |
2016 | Cardiology | Patterns of international normalized ratio values among new warfarin patients with non- valvular atrial fibrillation | |
2016 | Cardiology | Clinical and economic burden associated with cardiovascular events among patients with hyperlipidemia: A retrospective cohort study | |
2016 | Women's Health | The economic impact of symptomatic menopause among low-socioeconomic women in the United States | |
We have rich authorship and real-world evidence expertise with thousands of publications and presentations on a variety of life science topics in top-rated, peer-reviewed journals and industry proceedings.
We maintain relationships with universities and medical institutions to create a team of Key Opinion Leaders (KOLs) and faculty to consult and advise on publications.
The CDA team has an impressive peer-reviewed publication record, with international expertise in a wide variety of therapeutic areas. We have published more than 500 articles in high-quality journals such as JAMA, Medical Care, Health Policy, Curr Med Res Opin, J Med Econ, Value Health and many more. Our team members frequently review peer-reviewed journal articles and supply publication support.
145 Hudson Street, Suite 205
New York, NY 10013
332.264.0244
300 N. 5th Avenue, Suite 250
Ann Arbor, MI 48104
© 2026 Columbia Data Analytics, LLC. All rights reserved. Terms, Conditions, and Privacy